Testing pivmecillinam pills for E. coli kidney infection
Treatments studied
Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests if a switch to pivmecillinam pills after IV antibiotics works as well as standard oral antibiotics for E. coli febrile urinary tract infections. It aims to simplify treatment for patients who are already stable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a fever (at least 100.4°F) plus symptoms like side pain, nausea, or burning when urinating.
- Your urine culture shows E. coli bacteria that can be killed by the study drug.
- You have received IV antibiotics for at least 2 days and your fever is gone.
- You are not pregnant or breastfeeding.
- You do not have severe kidney problems, a kidney abscess, or a prostate infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial tests whether switching from short-term IV antibiotics to an oral antibiotic combo is safe and effective for ESBL urine infections. It may help you avoid staying on IV antibiotics as long, if your bacteria are the right match.
This trial tests whether the antibiotic cefotetan works as well as current standard treatments for E. coli bloodstream infections that start in the urinary tract. If you qualify, you may receive either cefotetan or the usual antibiotic therapy.
This trial tests a new antibiotic combo (ertapenem-zidebactam) against an existing one (ceftazidime-avibactam) for serious urinary tract or kidney infections in hospitalized patients. It aims to see if the new drug is as effective and safe.
This Phase 2 trial tests LBP-EC01 to treat a bladder infection (UTI) caused by drug-resistant E. coli. It may help by targeting the specific bacteria that make UTIs harder to cure with common antibiotics.
This trial tests whether one dose of intravenous (IV) antibiotics is as effective as the usual multiple-dose course for children with complicated urinary tract infections (UTIs) who need IV treatment in the emergency department. It aims to reduce hospital stays and the need for repeated IV lines.
This trial tests a combination of two antibiotics (cefepime and enmetazobactam) to treat complicated urinary tract infections that have spread to the blood. It aims to see if this new combination works better than other antibiotics and is safe for patients.
Hear when a new Febrile Urinary Tract Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.